(S (NP (JJ Clinical) (NN trial) (NNS registries)) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB monitor) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NN trial) (NN evidence) (CC and) (NN signal)))) (SBAR (WHADVP (WRB when)) (S (NP (JJ systematic) (NNS reviews)) (VP (VBP become) (PRT (IN out)) (PP (IN of) (NP (NN date)))))))))))) (. .))
(S (ADVP (RB However)) (, ,) (NP (DT this) (NN use)) (VP (VBZ has) (VP (VBN been) (VP (VBN limited) (PP (IN to) (NP (NN date))) (PP (IN due) (IN to) (NP (NP (NP (DT the) (JJ extensive) (JJ manual) (NN review)) (VP (VBN required) (S (VP (TO to) (VP (VB search) (PP (IN for))))))) (CC and) (NP (NP (NN screen)) (NP (JJ relevant) (NN trial) (NNS registrations)))))))) (. .))
(S (NP (PRP$ Our) (NN aim)) (VP (VBD was) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT a) (JJ new) (NN method)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (ADVP (RB partially)) (VP (VB automate) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (NN trial) (NNS registrations)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB be) (ADJP (JJ relevant) (PP (IN for) (NP (JJ systematic) (NN review) (NNS updates)))))))))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD identified) (NP (NP (CD 179) (JJ systematic) (NNS reviews)) (PP (IN of) (NP (NN drug) (NNS interventions)))) (PP (IN for) (NP (NP (NML (NN type) (CD 2)) (NN diabetes)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD included) (NP (NP (CD 537) (JJ clinical) (NNS trials)) (SBAR (WHNP (WDT that)) (S (VP (VBD had) (NP (NP (NNS registrations)) (PP (IN in) (NP (NNP ClinicalTrials.gov)))))))))))))) (. .))
(S (NP (PRP We)) (VP (VBD tested) (NP (NP (DT a) (NML (NN matrix) (NN factorisation)) (NN approach)) (SBAR (WHNP (WDT that)) (S (VP (VBZ uses) (NP (DT a) (VBN shared) (NN latent) (NN space)) (S (VP (TO to) (VP (VB learn) (SBAR (WHADVP (WRB how)) (S (VP (TO to) (VP (VB rank) (NP (JJ relevant) (NN trial) (NNS registrations)) (PP (IN for) (NP (DT each) (JJ systematic) (NN review)))))))))))))) (, ,) (S (VP (VBG comparing) (NP (DT the) (NN performance)) (PP (IN to) (NP (NN document) (NN similarity))) (PP (IN to) (NP (NN rank) (JJ relevant) (NN trial) (NNS registrations)))))) (. .))
(S (NP (DT The) (CD two) (NNS approaches)) (VP (VBD were) (VP (VBN tested) (PP (IN on) (NP (NP (DT a) (NN holdout) (NN set)) (PP (IN of) (NP (NP (DT the) (JJS newest) (NNS trials)) (PP (IN from) (NP (NP (NP (DT the) (NN set)) (PP (IN of) (NP (NML (NN type) (CD 2)) (NN diabetes) (JJ systematic) (NNS reviews)))) (CC and) (NP (NP (DT an) (JJ unseen) (NN set)) (PP (IN of) (NP (CD 141) (JJ clinical) (NN trial) (NNS registrations)))))))))) (PP (IN from) (NP (NP (CD 17) (VBN updated) (JJ systematic) (NNS reviews)) (VP (VBN published) (PP (IN in) (NP (NP (DT the) (NML (NNP Cochrane) (NN Database))) (PP (IN of) (NP (JJ Systematic) (NNS Reviews)))))))))) (. .))
(S (NP (DT The) (NML (NN matrix) (NN factorisation)) (NN approach)) (VP (VBD outperformed) (NP (DT the) (NN document) (NN similarity) (NN approach)) (PP (IN with) (NP (NP (DT a) (JJ median) (NN rank)) (PP (IN of) (NP (CD 59) (CC and) (CD recall@100))) (PP (IN of) (NP (CD 60.9) (NN %))))) (, ,) (PP (VBN compared) (PP (IN to) (NP (NP (DT a) (JJ median) (NN rank)) (PP (IN of) (NP (CD 138) (CC and) (CD recall@100))) (PP (IN of) (NP (NP (CD 42.8) (NN %)) (PP (IN in) (NP (DT the) (NN document) (NN similarity) (NN baseline))))))))) (. .))
(S (PP (IN In) (NP (NP (DT the) (JJ second) (NN set)) (PP (IN of) (NP (NP (JJ systematic) (NNS reviews)) (CC and) (NP (PRP$ their) (NNS updates)))))) (, ,) (NP (DT the) (ADJP (JJS highest) (VBG performing)) (NN approach)) (VP (VP (VBD used) (NP (NN document) (NN similarity))) (CC and) (VP (VBD gave) (NP (NP (DT a) (JJ median) (NN rank)) (PP (IN of) (NP (CD 67))))) (PRN (-LRB- -LRB-) (NP (NP (NN recall@100)) (PP (IN of) (NP (CD 62.9) (NN %)))) (-RRB- -RRB-))) (. .))
(S (NP (DT The) (JJ proposed) (NN method)) (VP (VBD was) (ADJP (JJ useful) (PP (IN for) (S (VP (VBG ranking) (NP (NN trial) (NNS registrations)) (S (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (JJ manual) (NN workload)) (VP (VBN associated) (PP (IN with) (S (VP (VBG finding) (NP (JJ relevant) (NNS trials)) (PP (IN for) (NP (JJ systematic) (NN review) (NNS updates)))))))))))))))) (. .))
(S (NP (DT The) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (DT the) (NN approach)) (VP (MD could) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (DT a) (JJ semi-automated) (NN pipeline))))) (PP (IN for) (S (VP (VBG monitoring) (NP (ADJP (RB potentially) (JJ new)) (NN evidence)) (PP (IN for) (NP (NP (NN inclusion)) (PP (IN in) (NP (DT a) (NN review) (NN update)))))))))))))) (. .))
